Project Grant R21NS147283
- This $488,232 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, is funding research by The Washington University to explore the mechanisms by which astrocytes, a type of glial cell, support the metabolic needs of neighboring neurons in the brain. The 5-year project aims to investigate the regulation of intracellular and...
- This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $499,979 to The Salk Institute for Biological Studies to conduct research aimed at "Uncovering Astrocyte Contributions to Neuropathic Pain". The research project seeks to better understand the role of astrocytes, a type of glial cell in the central nervous system,...
- This federal Project Grant award of $458,189 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award supports research focused on understanding how specific membrane-remodeling factors regulate oligodendrocyte membrane dynamics and myelination in the central nervous system. The research aims to elucidate the mechanisms by which these factors shape...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $168,455 to New York University School of Medicine to investigate region-specific factors in reactive astrocytes during neuroinflammation. The research project aims to explore the heterogeneous responses of astrocytes, the most abundant brain glial cells, to inflammation, focusing on...
- This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $361,975 to support research focused on developing chemical strategies for imaging and manipulating astrocytes in the brain. The project aims to expand the capabilities of an astrocyte-targeting chemical tag to enable direct visualization and modulation of astrocyte...
- This $632,776 federal Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) aims to fundamentally advance the understanding of astrocyte physiology. The grant supports research at Baylor College of Medicine to use novel genetically encoded voltage indicators (GEVIs) to measure astrocyte membrane potential and local neural activity in the mouse visual...
- This $536,617 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research conducted by Oregon Health & Science University (OHSU) to understand the mechanisms of adult neural regeneration using planarian and zebrafish model organisms. The research aims to elucidate how adult stem cells can generate the appropriate diversity of...
- This $614,009 federal Project Grant award was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research into the molecular mechanisms of oligodendrocyte myelination and remyelination, which are critical processes for addressing demyelinating diseases of the central nervous system like multiple sclerosis. The awardee, Children's Hospital...
- This $576,142 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research conducted by Oregon Health & Science University (OHSU) to enhance understanding of oligodendrocyte (OL) development and myelination in the central nervous system. The key objectives of the 5-year project are to: Define the cellular mechanisms by which the...
- This federal Project Grant award of $446,126 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a new bioassay to study astrocyte borders and profile their functional states in the context of diverse non-neural cell populations. The key objectives are to optimize the bioassay by combining injectable cellulose-based hydrogels with viral vectors to...
This Project Grant award, totaling $429,000.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award will fund research at Oregon Health & Science University (OHSU) to investigate the fundamental interactions between astrocytes and oligodendrocytes, two major types of glial cells in the central nervous system, and how these interactions contribute to proper nervous system function. The research aims to fully define the cellular and molecular bases of astrocyte-oligodendrocyte interactions, identify novel proteins at the astrocyte-myelin interface, and understand how alterations in astrocyte development impact oligodendrocyte development and myelination. The award period runs from September 24, 2025 through August 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $429.0k | 9/24/25 |